Morgan Stanley’s Taiwan Liposome TLC Stock Holding History
Bought
Maintained
Sold
Other funds holding TLC
Morgan Stanley's TLC Position: Q4 2019 in Review
Morgan Stanley sold out of Taiwan Liposome (TLC) in Q4 2019, closing a stake of 100 shares — an estimated $1K sold.
Morgan Stanley first reported a position in TLC in Q4 2018 and held it in 4 quarters. The position peaked at $1.5M in Q1 2019. 6 funds tracked by Wall St. Rank hold TLC as of Q4 2019.
- Morgan Stanley reported no remaining Taiwan Liposome position as of Q4 2019 after selling out during the quarter.
- Morgan Stanley sold 100 Taiwan Liposome shares in Q4 2019, an estimated $1K.
- Morgan Stanley first reported a position in Taiwan Liposome in Q4 2018 and held it in 4 quarters.
- Morgan Stanley's Taiwan Liposome position peaked at $1.5M in Q1 2019.
- 6 funds tracked by Wall St. Rank held Taiwan Liposome as of Q4 2019.
Based on Morgan Stanley's 13F filing for Q4 2019, filed 14 Feb 2020.